Gemini normalized the inflammatory response at the cellular level in stage 3 and 4 CKD patients – – Gemini could potentially ...

Icotrokinra is a first-in-class investigational targeted oral peptide that selectively blocks the IL-23 receptor 1 ...

Title : APG990, a monoclonal antibody targeting OX40L, demonstrates safety and an extended half-life in healthy subjects (P3237) Presenter : Carl Dambkowski, M.D., Chief Medical Officer, Apogee ...

Bioxodes SA, a clinical stage biopharmaceutical company developing novel therapies for the prevention and treatment of thrombotic and inflammatory diseases, today announces encouraging second interim ...

The Cyprus Development Bank (CDB bank) on Thursday issued a clarification regarding media reports suggesting that the company may be the subject of an acquisition.“There is nothing specific to ...

WILMINGTON, NEW CASTLE, DE, UNITED STATES, September 2, 2025 /EINPresswire.com/ -- According to the report published by Allied Market Research, the global hyperscale data center market generated $59.0 ...

ABD-147 is a targeted radiopharmaceutical biologic therapy designed to deliver Actinium-225 (225Ac), a highly potent alpha-emitting radioisotope, to solid tumors expressing delta-like ligand 3 (DLL3) ...

This story is a Media Miss by the right as only 23% is from right-leaning media. 76% left coverage23% right coverage A joint investigation by three news outlets has uncovered Israeli military ...